Is your Pharmaceutical Company Seen as a Leader? | MD Analytics ULC
Menu

Which Pharmaceutical Companies are Seen as Leaders?

By Tyler Hassman, CEO

May 29, 2017

Corporate reputation plays an important role in enabling companies to further differentiate their products in highly competitive markets. As a result our team sought to better understand how pharmaceutical manufacturers are currently perceived. After surveying Canadian GPs, we noticed several trends. One of which was when assessing overall pharma leadership, there was no unanimous leader. However, when asked about specific therapeutic areas, GP perceptions of leadership varied for different companies.

Read More

We asked 180 Canadian physicians of which pharmaceutical company they have the highest opinion. Overall, there was no clear winner. However, when asked by disease areas, some leaders emerge.

Top companies seen as leader in…(% ranked 1-3)

  • Neurology: Novartis (46%); Roche (38%); Lilly (37%)
  • Cardiovascular Disease: Merck (51%); AstraZeneca (43%); Pfizer (43%)
  • Respiratory: GSK (69%); AstraZeneca (67%); Boehringer Ingelheim (56%)
  • Gastroenterology: Merk (67%); Pfizer (61%); Janssen (56%)
  • Diabetes: Lilly (50%); Novo Nordisk (40%); AstraZeneca (37%)
  • Psoriasis: Leo (65%); Galderma (57%); Janssen (24%)

Past Survey Data

Pharma Leaders of Digital Media

While social media and digital tools have been playing an increasingly significant role in the personal lives of HCPs for many years now, use of these channels in a...

read more

Past Survey Data

Pharma Leaders of Digital Media

While social media and digital tools have been playing an increasingly significant role in the personal lives of HCPs for many years now, use of these channels in a...

read more

We are here to answer your questions.